Titan Pharmaceuticals Provides Opinion of Counsel Covering Issuance and Resale of Shares Underlying Public Warrants October 7, 2015
Titan Pharmaceuticals Announces FDA's Acceptance of Resubmission of New Drug Application for Probuphine September 28, 2015
Titan Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference September 3, 2015
Titan Pharmaceuticals Announces Resubmission of the New Drug Application for Probuphine for the Maintenance Treatment of Opioid Addiction August 31, 2015
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2015 Financial Results August 11, 2015
Titan Pharmaceuticals Presents Nonclinical Data Supporting Use of ProNeura Drug Delivery Platform in Parkinson's Disease June 17, 2015
Titan Pharmaceuticals Reports Positive Results From Phase 3 Study of Probuphine for Opioid Addiction June 8, 2015
